Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children

被引:69
作者
Essajee, SM
Kim, M
Gonzalez, C
Rigaud, M
Kaul, A
Chandwani, S
Hoover, W
Lawrence, R
Spiegel, H
Pollack, H
Krasinski, K
Borkowsky, W
机构
[1] NYU Med Ctr, Bellevue Hosp, Dept Pediat, New York, NY 10016 USA
[2] NYU Med Ctr, Bellevue Hosp, Dept Environm Med, New York, NY 10016 USA
[3] NYU Med Ctr, Bellevue Hosp, Dept Med, New York, NY 10016 USA
[4] St Vincents Hosp, Dept Pediat, New York, NY USA
关键词
highly active antretroviral therapy (HAART); pediatric AIDS;
D O I
10.1097/00002030-199912240-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine the long-term immunologic and virologic effects of highly active antiretroviral therapy (HAART) in children with AIDS. Design: A prospective observational study. Setting: Two pediatric HIV clinics. Participants: Twenty-five protease-inhibitor naive HIV-infected children (aged 2-18 years) with advanced disease (CD4 less than or equal to 6%). Intervention: HAART tone protease inhibitor and one or more nucleoside analogs). Diphtheria and tetanus immunization in six patients after 18 months of therapy. Main outcome measures: Changes in percentage of CD4 cells and plasma HIV-1 RNA levels; post-treatment assays of lymphoproliferative responses to recall antigens; CD4 cell memory phenotype. Results: Median duration of follow-up was 18.8 months (range, 7.5-28 months). At baseline the CD4 cell percentage was 2% (range, 0-6%), this increased significantly to 16% (range, 3-48%) above baseline at 12 months (P = 0.002). The mean maximum CD4 cell increase was 20.7% (range 4-48%) which corresponds to 657 x 10(6) cells/l (range, 30-2240 x 10(6) cells/l) above baseline. By contrast, the median viral load was not significantly lower at 12 months than at baseline (P = 0.34), and only 25% of the patients had sustained undetectable viral load. Of the reconstituted CD4 cells 70% were naive, and none of the subjects had lymphoproliferative responses to tetanus and diphtheria although 40% did develop responses to Candida, an environmental antigen. A single immunization with diphtheria and tetanus toroid produced lymphoproliferative responses to tetanus in th ree out of six patients. Conclusions: HAART was associated with sustained increases in CD4 cell counts, despite a high incidence of 'virologic failure'. CD4 counts and the proportion of naive cells were higher than have been reported in adults, which may be a reflection of greater thymic activity in children. Memory cell clones for antigens encountered in the past which are not prevalent before therapy could not be expanded without additional antigenic exposure. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:2523 / 2532
页数:10
相关论文
共 40 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   HIV INDUCES THYMUS DEPLETION INVIVO [J].
BONYHADI, ML ;
RABIN, L ;
SALIMI, S ;
BROWN, DA ;
KOSEK, J ;
MCCUNE, JM ;
KANESHIMA, H .
NATURE, 1993, 363 (6431) :728-732
[3]   ANTIBODY-RESPONSES TO BACTERIAL TOXOIDS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BORKOWSKY, W ;
STEELE, CJ ;
GRUBMAN, S ;
MOORE, T ;
LARUSSA, P ;
KRASINSKI, K .
JOURNAL OF PEDIATRICS, 1987, 110 (04) :563-566
[4]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[5]  
Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO
[6]  
2-E
[7]   HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J].
Connors, M ;
Kovacs, JA ;
Krevat, S ;
GeaBanacloche, JC ;
Sneller, MC ;
Flanigan, M ;
Metcalf, JA ;
Walker, RE ;
Falloon, J ;
Baseler, M ;
Stevens, R ;
Feuerstein, I ;
Masur, H ;
Lane, HC .
NATURE MEDICINE, 1997, 3 (05) :533-540
[8]   CD45 isoforms expression on CD4(+) and CD8(+) T cells throughout life, from newborns to centenarians: Implications for T cell memory [J].
Cossarizza, A ;
Ortolani, C ;
Paganelli, R ;
Barbieri, D ;
Monti, D ;
Sansoni, P ;
Fagiolo, U ;
Castellani, G ;
Bersani, F ;
Londei, M ;
Franceschi, C .
MECHANISMS OF AGEING AND DEVELOPMENT, 1996, 86 (03) :173-195
[9]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[10]  
Deeks S., 1997, 37 INT C ANT AG CHEM